| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/19/2012 | WO2011150347A3 Non-peptide bdnf neurotrophin mimetics |
| 01/19/2012 | WO2011143383A3 Protease catalyzed in situ end capping of oligopeptides in aqueous media |
| 01/19/2012 | WO2011137319A3 Stabilized fibronectin domain compositions, methods and uses |
| 01/19/2012 | WO2011136469A3 Pharmaceutical composition using connective tissue growth factor |
| 01/19/2012 | WO2011131896A3 Peptide derivatives, preparation thereof and uses thereof as vectors |
| 01/19/2012 | WO2011116262A3 Compositions and methods for diagnosing and treating urinary tract infections |
| 01/19/2012 | WO2011113005A3 Compositions and methods for combinations of oligoamines with 2-difluoromethylornithine (dfmo) |
| 01/19/2012 | WO2011112983A3 Psrp is a protective antigen against pneumococcal infection |
| 01/19/2012 | WO2011112873A3 Extracorporeal immunoadsorption treatment |
| 01/19/2012 | WO2011112859A3 Methods relating to olanzapine pharmacogenetics |
| 01/19/2012 | WO2011109398A3 Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
| 01/19/2012 | WO2011109106A3 Immunogenic compositions against human progastrin peptides |
| 01/19/2012 | WO2011106376A3 Use of microvesicles in the treatment of medical conditions |
| 01/19/2012 | WO2011087491A9 Parstatin peptides and uses thereof |
| 01/19/2012 | WO2010082177A3 Compounds for cosmetic and dermopharmaceutical |
| 01/19/2012 | US20120017290 Genome editing of a Rosa locus using zinc-finger nucleases |
| 01/19/2012 | US20120017288 Anticoagulant Fusion Protein Anchored to Cell Membrane |
| 01/19/2012 | US20120016489 Textured bone block implants |
| 01/19/2012 | US20120016347 Seroma Control for Surgical Patients |
| 01/19/2012 | US20120016340 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 01/19/2012 | US20120016105 Purification of peptide conjugates by hydrophobic interaction chromatography |
| 01/19/2012 | US20120015892 Formulations of canfosfamide and their preparation |
| 01/19/2012 | US20120015891 Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof |
| 01/19/2012 | US20120015890 Use of Soluble Forms of CD83 and Nucleic Acids Encoding them for the Treatment or Prevention of Diseases |
| 01/19/2012 | US20120015889 Method for the administration of ligands, agonists of ligands of the tnf family with reduced toxicity |
| 01/19/2012 | US20120015888 T cell receptors and related materials and methods of use |
| 01/19/2012 | US20120015887 Synthetic peptide and uses thereof |
| 01/19/2012 | US20120015886 Method for preparing recombinant peptide from spider venom and method for relieving pain |
| 01/19/2012 | US20120015885 COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF |
| 01/19/2012 | US20120015884 Polypeptides for Specific Targeting to Otx2 Target Cells |
| 01/19/2012 | US20120015883 Peptoid and synthetic oligomers, pharmaceutical compositions and methods of using same |
| 01/19/2012 | US20120015882 Composition for regulating autonomic nervous activity and method for regulating autonomic nerve |
| 01/19/2012 | US20120015881 Kallikrein-inhibitor therapies |
| 01/19/2012 | US20120015880 Intranasal desmopressin administration |
| 01/19/2012 | US20120015879 Unitary combinations of FSH and hCG |
| 01/19/2012 | US20120015878 Use of adnf polypeptides for treating anxiety and depression |
| 01/19/2012 | US20120015877 Use of gdf traps to increase red blood cell levels |
| 01/19/2012 | US20120015876 Conjugates of glp-1 agonists and uses thereof |
| 01/19/2012 | US20120015875 Use Of Oxandrolone In The Treatment Of Burns And Other Wounds |
| 01/19/2012 | US20120015874 Novel inhibitors of retroviral reverse transcriptace |
| 01/19/2012 | US20120015873 Melanocortin analogs with antimicrobial activity |
| 01/19/2012 | US20120015872 Complement receptor 2 targeted complement modulators |
| 01/19/2012 | US20120015871 Complement receptor 2 targeted complement modulators |
| 01/19/2012 | US20120015870 Peptides and compositions for prevention of cell adhesion and methods of using same |
| 01/19/2012 | US20120015868 Metastin derivatives and use thereof |
| 01/19/2012 | US20120015867 Therapeutic peptides and method |
| 01/19/2012 | US20120015866 Prodrugs of Heteraromatic Compounds |
| 01/19/2012 | US20120015865 Novel class of cationic lipids for transporting active agents into cells |
| 01/19/2012 | US20120015820 Methods and compositions for polypeptide engineering |
| 01/19/2012 | US20120015396 Compositions and methods for modulating the acid-sensing ion channel (asic) |
| 01/19/2012 | US20120015042 Rna sequence-specific mediators of rna interference |
| 01/19/2012 | US20120015037 Functionalized nanoparticle, method for preparing the same and application thereof |
| 01/19/2012 | US20120015026 Pharmaceutical composition containing a drug and sirna |
| 01/19/2012 | US20120015024 Methods for treating tweak-related conditions |
| 01/19/2012 | US20120015006 Flowable collagen material for dural closure |
| 01/19/2012 | US20120015001 Methods of treating thyroid eye disease |
| 01/19/2012 | US20120014999 Diketopiperazine Microparticles with Defined Specific Surface Areas |
| 01/19/2012 | US20120014998 Modified chaperonin 10 |
| 01/19/2012 | US20120014979 Use of bcl6 inhibitors for treating autoimmune diseases |
| 01/19/2012 | US20120014974 Methods of modulating cell death based on the bit1/aes regulatory pathway |
| 01/19/2012 | US20120014973 Adenylyl cyclase-associated protein (cap1) and uses thereof as a target for immuno-modulation |
| 01/19/2012 | US20120014970 Therapeutic Compositions for Treatment of Corneal Disorders |
| 01/19/2012 | US20120014965 Compositions and methods of treating tumors |
| 01/19/2012 | US20120014964 Alpha synuclein toxicity |
| 01/19/2012 | US20120014961 Antibodies that inhibit tslp activity |
| 01/19/2012 | US20120014959 Wise/sost nucleic acid sequences and amino acid sequences |
| 01/19/2012 | US20120014956 Methods and compositions for predicting responsiveness to treatment with tnf-alpha inhibitor |
| 01/19/2012 | US20120014953 Treating and evaluating inflammatory disorders |
| 01/19/2012 | US20120014952 Complement receptor 2 targeted complement modulators |
| 01/19/2012 | US20120014949 Serum Biomarkers For Early Detection Of Acute Cellular Rejection |
| 01/19/2012 | US20120014948 Genetic products differentially expressed in tumors and use thereof |
| 01/19/2012 | US20120014947 Methods and compositions to reduce liver damage associated with conditions or therapies that affect the immune system |
| 01/19/2012 | US20120014942 Method for the diagnosis and prognosis of malignant diseases |
| 01/19/2012 | US20120014939 Methods and compositions for the treatment and diagnosis of haemorrhagic conversion |
| 01/19/2012 | US20120014938 Angiogenic Tyrosyl t-RNA Synthetase Compositions and Methods |
| 01/19/2012 | US20120014937 Human Beta-Adrenergic receptor kinase polypeptide and methods |
| 01/19/2012 | US20120014936 Methods and compositions for cns delivery of heparan n-sulfatase |
| 01/19/2012 | US20120014935 Recombinant human cln2 protein and methods of its production and use |
| 01/19/2012 | US20120014934 Enhanced Natural Colors |
| 01/19/2012 | US20120014925 Self-Assembling Peptides Incorporating Modifications and Methods of Use Thereof |
| 01/19/2012 | US20120014920 Annexin and its use to treat inflammatory disorders |
| 01/19/2012 | US20120014919 Modulation of socs expression in therapeutic regimens |
| 01/19/2012 | US20120014918 Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as dhodh inhibitors |
| 01/19/2012 | US20120014917 Methods of treating hiv patients with anti-fibrotics |
| 01/19/2012 | US20120014916 Polyalkylene polymer compounds and uses thereof |
| 01/19/2012 | US20120014915 Estriol Therapy for Autoimmune and Neurodegenerative Disease and Disorders |
| 01/19/2012 | US20120014914 Inhibitors of serine proteases, particularly hcv ns3-ns4a proteases |
| 01/19/2012 | US20120014913 Process for preparing antiviral compounds |
| 01/19/2012 | US20120014912 Palatable pharmaceutical composition |
| 01/19/2012 | US20120014911 Regulators of the Interferon-Alpha Receptor 1 (IFNAR1) Chain of the Interferon Receptor |
| 01/19/2012 | US20120014910 Compositions and methods for treating symptoms associated with menopause, hormonal variations and arthritis |
| 01/19/2012 | US20120014906 Organic compounds |
| 01/19/2012 | US20120014905 Conugated proteins and peptides |
| 01/19/2012 | US20120014904 Vascular delivery systems |
| 01/19/2012 | US20120014886 Soothing cosmetic or pharmaceutical composition comprising a peptide which activates hmg-coa reductase |
| 01/19/2012 | US20120014885 Personal Care Compositions and Methods for Their Use |
| 01/19/2012 | US20120014879 USE OF TUMOR NECROSIS FACTOR-alpha RECEPTOR p75 FOR TREATMENT OF ISCHEMIA-INDUCED NEOVASCULARIZATION |
| 01/19/2012 | US20120014877 COMPOSITIONS AND METHODS TO TREAT CANCER WITH CpG RICH DNA AND CUPREDOXINS |
| 01/19/2012 | US20120014876 Antagonistic peptides for frizzled-1 and frizzled-2 |
| 01/19/2012 | US20120014874 Photosensitizer-metal nanoparticle charge complex and composition containing the complex for photodynamic therapy or diagnosis |